EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives

Shimon Ben-Shabat iD, Ludmila Yarmolinsky iD, Nitzan Sharon, Taima Zeadnaa-Aldda, Shir Dayan iD, Boris Khalfin iD, Sigal Fleisher-Berkovich iD

Biomolecules · 2026

DOI: 10.3390/biom16020225 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Biomolecules, 2026. Verfasst von Shimon Ben-Shabat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Cannabinoids, Neurodegenerative Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases are a large and complex group of neurological disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, multiple sclerosis, and so on, which adversely affect the physical and mental health of millions of people globally. Unfortunately, these diseases currently have no cure; only symptomatic treatment is available. Therefore, there is still a growing interest in using cannabinoids to treat neurodegenerative diseases. This systematic review examines the interrelationship between cannabinoids, the blood–brain barrier, and neurodegeneration, and their mutual effects. The objective of this review is to provide an overview of the endocannabinoid system at the neurovascular interface, the alterations and dysregulation of the ECS in neurodegenerative diseases, the interactions of phytocannabinoids with the blood–brain barrier, and their therapeutic potential in the context of neurodegeneration. The findings may facilitate the targeted application of cannabinoids to address multiple aspects of neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierCannabinoidsNeurodegenerative DiseasesHumansAnimalsEndocannabinoids

Stichwörter der Autor:innen

blood–brain barriercannabinoidsneurodegeneration

Substanzen

CannabinoidsEndocannabinoids

Autor:innen und Institutionen

  • Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.

ORCID-Profile: Shimon Ben-Shabat, Ludmila Yarmolinsky, Shir Dayan, Boris Khalfin, Sigal Fleisher-Berkovich

Förderung

  • Israel Science Foundation

Zitieren

APA

Ben-Shabat, S., Yarmolinsky, L., Sharon, N., Zeadnaa-Aldda, T., Dayan, S., Khalfin, B., & Fleisher-Berkovich, S. (2026). Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives. Biomolecules. https://doi.org/10.3390/biom16020225

Vancouver

Ben-Shabat S, Yarmolinsky L, Sharon N, Zeadnaa-Aldda T, Dayan S, Khalfin B, et al. Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives. Biomolecules. 2026. doi:10.3390/biom16020225

BibTeX
@article{BenShabat2026,
  author = {Ben-Shabat, Shimon and Yarmolinsky, Ludmila and Sharon, Nitzan and Zeadnaa-Aldda, Taima and Dayan, Shir and Khalfin, Boris and Fleisher-Berkovich, Sigal},
  title = {Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16020225}
}
Kostenlos starten →